
William P. Neuder
Examiner (ID: 10341)
| Most Active Art Unit | 3672 |
| Art Unit(s) | 3672, 2899, 3625, 3642, 3506 |
| Total Applications | 4583 |
| Issued Applications | 4090 |
| Pending Applications | 166 |
| Abandoned Applications | 332 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19089687
[patent_doc_number] => 11951106
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
[patent_app_type] => utility
[patent_app_number] => 17/304309
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 19
[patent_no_of_words] => 13322
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17304309
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/304309 | Method of increasing bioavailability and/or prolonging ophthalmic action of a drug | Jun 16, 2021 | Issued |
Array
(
[id] => 17124282
[patent_doc_number] => 20210299050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => Solid Oral Sulfate Salt Formulations For Cleansing A Colon And Methods Of Using Same
[patent_app_type] => utility
[patent_app_number] => 17/347469
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/347469 | Solid oral sulfate salt formulations for cleansing a colon and methods of using same | Jun 13, 2021 | Issued |
Array
(
[id] => 18496147
[patent_doc_number] => 20230218693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 18/000918
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000918
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000918 | HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME | Jun 10, 2021 | Pending |
Array
(
[id] => 18522982
[patent_doc_number] => 20230233634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => PROCYANIDINS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION TRIGGERED BY COVID-19
[patent_app_type] => utility
[patent_app_number] => 17/928797
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17928797
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/928797 | PROCYANIDINS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION TRIGGERED BY COVID-19 | Jun 8, 2021 | Pending |
Array
(
[id] => 18341229
[patent_doc_number] => 11638697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Solid oral sulfate salt formulations for cleaning a colon and methods of using same
[patent_app_type] => utility
[patent_app_number] => 17/340973
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10395
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340973
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/340973 | Solid oral sulfate salt formulations for cleaning a colon and methods of using same | Jun 6, 2021 | Issued |
Array
(
[id] => 19256947
[patent_doc_number] => 12016976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Submucosal lifting compositions and methods of same
[patent_app_type] => utility
[patent_app_number] => 17/335235
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6724
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17335235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/335235 | Submucosal lifting compositions and methods of same | May 31, 2021 | Issued |
Array
(
[id] => 17080715
[patent_doc_number] => 20210275721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => MICROFLUIDIC EXTRUSION
[patent_app_type] => utility
[patent_app_number] => 17/328633
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328633
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328633 | Microfluidic extrusion | May 23, 2021 | Issued |
Array
(
[id] => 17619030
[patent_doc_number] => 11338057
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Microfluidic extrusion
[patent_app_type] => utility
[patent_app_number] => 17/328854
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 60
[patent_no_of_words] => 25267
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328854
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328854 | Microfluidic extrusion | May 23, 2021 | Issued |
Array
(
[id] => 18596021
[patent_doc_number] => 20230270812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => COMPOSITION TO BE USED FOR STRENGTHENING THE IMMUNE SYSTEM IN HUMAN AND ANIMAL TO ACQUIRE PAN-IMMUNITY
[patent_app_type] => utility
[patent_app_number] => 17/922884
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/922884 | COMPOSITION TO BE USED FOR STRENGTHENING THE IMMUNE SYSTEM IN HUMAN AND ANIMAL TO ACQUIRE PAN-IMMUNITY | May 6, 2021 | Abandoned |
Array
(
[id] => 17050613
[patent_doc_number] => 20210260047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS
[patent_app_type] => utility
[patent_app_number] => 17/314272
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314272 | Methods and devices for the treatment of ocular diseases in human subjects | May 6, 2021 | Issued |
Array
(
[id] => 17398134
[patent_doc_number] => 20220040224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => NITRIC OXIDE TOPICAL APPLICATION APPARATUS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/244158
[patent_app_country] => US
[patent_app_date] => 2021-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244158
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/244158 | Nitric oxide topical application apparatus and methods | Apr 28, 2021 | Issued |
Array
(
[id] => 17035232
[patent_doc_number] => 20210252190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Microfluidic Extrusion
[patent_app_type] => utility
[patent_app_number] => 17/239013
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17239013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/239013 | Microfluidic extrusion | Apr 22, 2021 | Issued |
Array
(
[id] => 17020789
[patent_doc_number] => 20210244660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/236295
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236295
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/236295 | Orally administered corticosteroid compositions | Apr 20, 2021 | Issued |
Array
(
[id] => 17466671
[patent_doc_number] => 11273128
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-03-15
[patent_title] => Elagolix formulation
[patent_app_type] => utility
[patent_app_number] => 17/231118
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10665
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231118
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231118 | Elagolix formulation | Apr 14, 2021 | Issued |
Array
(
[id] => 16961476
[patent_doc_number] => 20210212975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/219039
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219039
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219039 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME | Mar 30, 2021 | Abandoned |
Array
(
[id] => 18434371
[patent_doc_number] => 20230181665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES MELLITUS 10 TYPE I AND TYPE II AND THYROID DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/912625
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912625
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/912625 | TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES MELLITUS 10 TYPE I AND TYPE II AND THYROID DISEASES | Mar 18, 2021 | Abandoned |
Array
(
[id] => 19058990
[patent_doc_number] => 11938184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Compositions and methods for treating Crohn's Disease and related conditions and infections
[patent_app_type] => utility
[patent_app_number] => 17/203687
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12648
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203687
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203687 | Compositions and methods for treating Crohn's Disease and related conditions and infections | Mar 15, 2021 | Issued |
Array
(
[id] => 18994692
[patent_doc_number] => 11911511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Anticancer compositions
[patent_app_type] => utility
[patent_app_number] => 17/201811
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10947
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201811
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/201811 | Anticancer compositions | Mar 14, 2021 | Issued |
Array
(
[id] => 16913824
[patent_doc_number] => 20210186916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
[patent_app_type] => utility
[patent_app_number] => 17/194780
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194780
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194780 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Mar 7, 2021 | Issued |
Array
(
[id] => 20465377
[patent_doc_number] => 12521406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-13
[patent_title] => Use of compounds in the treatment of fungal infections
[patent_app_type] => utility
[patent_app_number] => 17/908079
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16505
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908079
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908079 | Use of compounds in the treatment of fungal infections | Mar 1, 2021 | Issued |